Show metadata Hide metadata

(19)

(11)

2 744 911

(13)

(51)

IPC

C07K16/28(2006-01-01)

C07K16/46(2006-01-01)

A61K39/395(2006-01-01)

A61P31/00(2006-01-01)

A61P35/00(2006-01-01)

(21) (22)

Application

2019105699, 2017-08-10

(24)

Start date

2017-08-10

(22)

Actual filing date

2017-08-10

(45)

Published

2021-03-17

(72)

Inventor

Konnai, SatoruOhashi, KazuhikoMurata, ShiroOkagawa, TomohiroNishimori, AsamiMaekawa, NaoyaSuzuki, YasuhikoNakajima, Chie

(73)

Holder

National University Corporation Hokkaido UniversityFuso Pharmaceutical Industries, Ltd.

ANTIBODY AGAINST PD-L1 Russian patent published in 2021 - IPC C07K16/28 C07K16/46 A61K39/395 A61P31/00 A61P35/00

Abstract RU 2744911 C2

FIELD: biotechnology.

SUBSTANCE: invention relates to the field of biotechnology, particularly to an antibody against PD-1, and to a pharmaceutical composition containing such antibody. Also disclosed is an artificial genetic DNA encoding such antibody or its light or heavy chain, as well as a vector and a cell containing such DNA. Invention also relates to a method for producing an antibody against PD-1 which provides cultivation of said host cell.

EFFECT: invention allows effectively preventing and/or treating infection or a malignant growth.

19 cl, 14 dwg, 2 tbl, 3 ex

Similar patents RU2744911C2

Title	Year	Author	Number
ANTIBODY AGAINST PD-L1	2017	Konnai, Satoru Ohashi, Kazuhiko Murata, Shiro Okagawa, Tomohiro Nishimori, Asami Maekawa, Naoya Suzuki, Yasuhiko Nakajima, Chie	RU2744862C2
ANTIBODY AGAINST LAG-3	2017	Konnai, Satoru Ohashi, Kazuhiko Murata, Shiro Okagawa, Tomohiro Nishimori, Asami Maekawa, Naoya Suzuki, Yasuhiko Nakajima, Chie	RU2744866C2
ANTI-PD-L1 ANTIBODY FOR PD-L1 DETECTION	2018	Konnai, Satoru Ohashi, Kazuhiko Murata, Shiro Okagawa, Tomohiro Nishimori, Asami Maekawa, Naoya Takagi, Satoshi Kagawa, Yumiko Suzuki, Yasuhiko Nakajima, Chie	RU2758723C2
ANTIBODY AGAINST SIRPα	2019	Matozaki Takashi Sue Mayumi Nakamura Kensuke Yoshimura Chigusa	RU2791002C2
ANTI-LIGAND 1 ANTIBODY OF PROGRAMMED CELL DEATH (PD-L1), ITS ANTIGEN-BINDING FRAGMENT AND THEIR MEDICAL APPLICATION	2016	Tsyuj Syandun Khu Tsiyue Syuj Shaoyu Tsuj Dunbin Tszin Khoutsun Tao Vejkan Chzhan Lyanshan Tsao Gotsin Sun Pyaoyan	RU2727914C2
MYL9 ANTIBODY	2017	Nakayama, Toshinori Kimura, Motoko Hayashizaki, Koji Hirayama, Toshifumi Kakuta, Jungo Sakamoto, Yoshimasa Gejima, Ryu Tokita, Daisuke Muramoto, Kenzo Imai, Toshio	RU2741802C2
ANTIBODY AGAINST CD147	2018	Fukuchi, Keisuke Nanai, Kayoko Amano, Masato Yoneda, Kozo Totoki, Yusuke Yamamoto, Shoji	RU2785293C2
ANTI-TFR ANTIBODIES AND USE THEREOF IN TREATING PROLIFERATIVE AND INFLAMMATORY DISORDERS	2016	Launay, Pierre Belanger, Coralie Souchet, Herve	RU2737637C2
ANTI-PD-1 ANTIBODY AND USE THEREOF	2017	Li Qiang Zheng Yuncheng Yang Lu Ma Xinlu Li Yuanli	RU2739610C1
HUMAN TLR7 ANTIBODY	2019	Miyake, Kensuke Murakami, Yusuke Motoi, Yuji Kanno, Atsuo Shimizu, Toshiyuki Ohto, Umeharu Shimozato, Takaichi Manno, Atsushi Kagari, Takashi Ishiguro, Jun Nakamura, Kensuke Isobe, Takashi	RU2808123C2

RU 2 744 911 C2

Authors

Konnai, Satoru

Ohashi, Kazuhiko

Murata, Shiro

Okagawa, Tomohiro

Nishimori, Asami

Maekawa, Naoya

Suzuki, Yasuhiko

Nakajima, Chie

Dates

2021-03-17—Published

2017-08-10—Filed